Novartis AG ADR (NVS)vsSonida Senior Living Inc (SNDA)
NVS
Novartis AG ADR
$147.85
+3.44%
HEALTHCARE · Cap: $282.11B
SNDA
Sonida Senior Living Inc
$37.96
+1.23%
HEALTHCARE · Cap: $1.79B
Smart Verdict
WallStSmart Research — data-driven comparison
Novartis AG ADR generates 16719% more annual revenue ($56.58B vs $336.39M). NVS leads profitability with a 23.9% profit margin vs -21.0%. SNDA appears more attractively valued with a PEG of 2.04. NVS earns a higher WallStSmart Score of 51/100 (C-).
NVS
Buy51
out of 100
Grade: C-
SNDA
Avoid27
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-52.5%
Fair Value
$109.60
Current Price
$147.85
$38.25 premium
Intrinsic value data unavailable for SNDA.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Mega-cap, among the largest globally
Every $100 of equity generates 35 in profit
Strong operational efficiency at 30.5%
Keeps 24 of every $100 in revenue as profit
Generating 2.9B in free cash flow
No standout strengths identified
Areas to Watch
Expensive relative to growth rate
Grey zone — moderate risk
Revenue declined 0.7%
Earnings declined 9.3%
Expensive relative to growth rate
Smaller company, higher risk/reward
Operating margin of 2.8%
Weak financial health signals
Comparative Analysis Report
WallStSmart ResearchBull Case : NVS
The strongest argument for NVS centers on Market Cap, Return on Equity, Operating Margin. Profitability is solid with margins at 23.9% and operating margin at 30.5%.
Bull Case : SNDA
Revenue growth of 12.0% demonstrates continued momentum.
Bear Case : NVS
The primary concerns for NVS are PEG Ratio, Altman Z-Score, Revenue Growth.
Bear Case : SNDA
The primary concerns for SNDA are PEG Ratio, Market Cap, Operating Margin. Debt-to-equity of 8.45 is elevated, increasing financial risk.
Key Dynamics to Monitor
NVS profiles as a declining stock while SNDA is a turnaround play — different risk/reward profiles.
SNDA carries more volatility with a beta of 0.75 — expect wider price swings.
SNDA is growing revenue faster at 12.0% — sustainability is the question.
NVS generates stronger free cash flow (2.9B), providing more financial flexibility.
Bottom Line
NVS scores higher overall (51/100 vs 27/100), backed by strong 23.9% margins. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Novartis AG ADR
HEALTHCARE · DRUG MANUFACTURERS - GENERAL · USA
Novartis AG researches, develops, manufactures and markets medical devices worldwide. The company is headquartered in Basel, Switzerland.
Visit Website →Sonida Senior Living Inc
HEALTHCARE · MEDICAL CARE FACILITIES · USA
Sonida Senior Living, Inc. develops, owns, operates and manages senior living communities in the United States. The company is headquartered in Dallas, Texas.
Compare with Other DRUG MANUFACTURERS - GENERAL Stocks
Want to dig deeper into these stocks?